Traders sold shares of Colgate-Palmolive (NYSE:CL) on strength during trading hours on Monday. $34.66 million flowed into the stock on the tick-up and $67.22 million flowed out of the stock on the tick-down, for a money net flow of $32.56 million out of the stock. Of all stocks tracked, Colgate-Palmolive had the 2nd highest net out-flow for the day. Colgate-Palmolive traded up $0.44 for the day and closed at $70.06
CL has been the topic of a number of research analyst reports. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price on the stock in a report on Tuesday, January 16th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a report on Tuesday, December 19th. Deutsche Bank initiated coverage on Colgate-Palmolive in a report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 target price on the stock. Finally, Societe Generale downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 target price on the stock. in a report on Wednesday, November 29th. They noted that the move was a valuation call. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $77.71.
The company has a debt-to-equity ratio of 27.02, a quick ratio of 1.00 and a current ratio of 1.36. The firm has a market cap of $60,940.25, a price-to-earnings ratio of 30.73, a price-to-earnings-growth ratio of 2.58 and a beta of 0.79.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The company had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $3.92 billion. During the same quarter last year, the business posted $0.75 EPS. Colgate-Palmolive’s revenue for the quarter was up 4.6% on a year-over-year basis. equities analysts forecast that Colgate-Palmolive will post 3.18 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, May 15th. Shareholders of record on Friday, April 20th will be issued a dividend of $0.42 per share. The ex-dividend date is Thursday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a yield of 2.40%. Colgate-Palmolive’s payout ratio is presently 70.18%.
In other Colgate-Palmolive news, SVP John J. Huston sold 14,000 shares of Colgate-Palmolive stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $69.44, for a total transaction of $972,160.00. Following the transaction, the senior vice president now directly owns 100,508 shares of the company’s stock, valued at approximately $6,979,275.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Vice Chairman Franck J. Moison sold 30,000 shares of Colgate-Palmolive stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $69.70, for a total value of $2,091,000.00. Following the transaction, the insider now directly owns 211,048 shares in the company, valued at $14,710,045.60. The disclosure for this sale can be found here. Insiders have sold a total of 455,707 shares of company stock worth $32,443,427 over the last ninety days. Company insiders own 1.02% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the business. Virtue Capital Management LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter worth about $104,000. Jacobi Capital Management LLC raised its position in shares of Colgate-Palmolive by 125.5% in the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after acquiring an additional 803 shares in the last quarter. Krilogy Financial LLC raised its position in shares of Colgate-Palmolive by 23.0% in the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after acquiring an additional 289 shares in the last quarter. Calton & Associates Inc. bought a new position in shares of Colgate-Palmolive in the 4th quarter worth about $126,000. Finally, Bruderman Asset Management LLC bought a new position in shares of Colgate-Palmolive in the 2nd quarter worth about $126,000. 73.64% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.